Prognostic value of obesity in patients with cancer treated with immune checkpoint inhibitors: An updated meta-analysis and systematic review

被引:3
作者
Guo, Hui [1 ]
Lin, Xue-Ying [2 ]
Feng, Shuai [1 ]
Wang, Cong [1 ]
Yuan, Ling-Qin [1 ]
Sheng, Xiu-Gui [3 ,4 ]
Li, Da-Peng [1 ]
机构
[1] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Gynecol Oncol, 440 Jiyan Rd, Jinan 250117, Shandong, Peoples R China
[2] Liaocheng Dongchangfu Dist Maternal & Child Hlth H, Dept Surg, Liaocheng 252019, Shandong, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Gynecol Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, 113 Baohe St, Shenzhen 518116, Guangdong, Peoples R China
[4] Chinese Acad Med Sci & Peking Union Med Coll, Shenzhen Hosp, 113 Baohe St, Shenzhen 518116, Guangdong, Peoples R China
关键词
obesity; fat composition; cancer; immunotherapy; meta-analysis; BODY-MASS INDEX; OUTCOMES; IMMUNOTHERAPY; ASSOCIATION; TOMOGRAPHY; BIOMARKERS; ADIPOSITY; SURVIVAL; EFFICACY; THERAPY;
D O I
10.3892/mco.2023.2703
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Accumulating interest has been surging over the past few years regarding the effects of obesity on immunotherapy. In addition to the body mass index (BMI), imaging-quantified body fat compartments have been investigated. The present study aimed to evaluate the predictive value of the BMI and computed tomography (CT)-based body fat in patients with cancer receiving immunotherapy. For this purpose, the PubMed, MEDLINE, EMBASE and Cochrane databases were searched from January 2017 to July 2022. Clinical studies evaluating the association between BMI or body fat and survival of patients with cancer treated with immune checkpoint inhibitors (ICIs) were included. In total, 15 studies reporting on the BMI were included in the meta-analysis and 16 studies evaluating body fat were included in the systematic review. According to the classification of the World Health Organization, overweight and obese patients with ICI treatment showed improved overall survival [overweight vs. normal: Hazard ratio (HR)=0.79, 95% confidence interval (CI)=0.64-0.98, P=0.03; obese vs. normal: HR=0.75, 95% CI=0.60-0.94, P=0.013] and progression-free survival (overweight vs. normal: HR=0.82, 95% CI=0.70-0.97, P=0.02; obese vs. normal: HR=0.81, 95% CI=0.65-1.02, P=0.07). Among the articles investigating the effect of body fat composition on the efficacy of immunotherapy, a number of studies included various CT analysis techniques and cutoffs to define body fat composition. Associations of body fat with survival were contradictory in different patients with cancer treated with immunotherapy. Obesity was associated with better survival in patients with cancer treated with ICIs. Further analyses are required to demonstrate the prognostic value of body fat in patients with cancer immunotherapy.
引用
收藏
页数:15
相关论文
共 54 条
[11]   A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable [J].
Cortellini, Alessio ;
Bersanelli, Melissa ;
Buti, Sebastiano ;
Cannita, Katia ;
Santini, Daniele ;
Perrone, Fabiana ;
Giusti, Raffaele ;
Tiseo, Marcello ;
Michiara, Maria ;
Di Marino, Pietro ;
Tinari, Nicola ;
De Tursi, Michele ;
Zoratto, Federica ;
Veltri, Enzo ;
Marconcini, Riccardo ;
Malorgio, Francesco ;
Russano, Marco ;
Anesi, Cecilia ;
Zeppola, Tea ;
Filetti, Marco ;
Marchetti, Paolo ;
Botticelli, Andrea ;
Cappellini, Gian Carlo Antonini ;
De Galitiis, Federica ;
Vitale, Maria Giuseppa ;
Rastelli, Francesca ;
Pergolesi, Federica ;
Berardi, Rossana ;
Rinaldi, Silvia ;
Tudini, Marianna ;
Silva, Rosa Rita ;
Pireddu, Annagrazia ;
Atzori, Francesco ;
Chiari, Rita ;
Ricciuti, Biagio ;
De Giglio, Andrea ;
Iacono, Daniela ;
Gelibter, Alain ;
Occhipinti, Mario Alberto ;
Parisi, Alessandro ;
Porzio, Giampiero ;
Fargnoli, Maria Concetta ;
Ascierto, Paolo Antonio ;
Ficorella, Corrado ;
Natoli, Clara .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
[12]   Impact of CT-based body composition parameters at baseline, their early changes and response in metastatic cancer patients treated with immune checkpoint inhibitors [J].
Crombe, Amandine ;
Kind, Michele ;
Toulmonde, Maud ;
Italiano, Antoine ;
Cousin, Sophie .
EUROPEAN JOURNAL OF RADIOLOGY, 2020, 133
[13]   Body Mass Index and Its Association with Clinical Outcomes for Advanced Non-Small-Cell Lung Cancer Patients Enrolled on Eastern Cooperative Oncology Group Clinical Trials [J].
Dahlberg, Suzanne E. ;
Schiller, Joan H. ;
Bonomi, Philip B. ;
Sandler, Alan B. ;
Brahmer, Julie R. ;
Ramalingam, Suresh S. ;
Johnson, David H. .
JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (09) :1121-1127
[14]   Visceral adipose tissue secretome from early and late-stage oesophageal cancer patients differentially affects effector and regulatory T cells [J].
Davern, Maria ;
Bracken-Clarke, Dara ;
Donlon, Noel E. E. ;
Sheppard, Andrew D. D. ;
O'Connell, Fiona ;
Heeran, Aisling B. B. ;
Majcher, Klaudia ;
Conroy, Melissa J. J. ;
Mylod, Eimear ;
Butler, Christine ;
Donohoe, Claire ;
O'Donnell, Dearbhaile ;
Lowery, Maeve ;
Bhardwaj, Anshul ;
Ravi, Narayanasamy ;
Melo, Ashanty A. A. ;
O'Sullivan, Jacintha ;
Reynolds, John V. V. ;
Lysaght, Joanne .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (09) :6583-6599
[15]   Association of Systemic Inflammation Index and Body Mass Index with Survival in Patients with Renal Cell Cancer Treated with Nivolumab [J].
De Giorgi, Ugo ;
Procopio, Giuseppe ;
Giannarelli, Diana ;
Sabbatini, Roberto ;
Bearz, Alessandra ;
Buti, Sebastiano ;
Basso, Umberto ;
Mitterer, Manfred ;
Ortega, Cinzia ;
Bidoli, Paolo ;
Ferrau, Francesco ;
Crino, Lucio ;
Frassoldati, Antonio ;
Marchetti, Paolo ;
Mini, Enrico ;
Scoppola, Alessandro ;
Verusio, Claudio ;
Fornarini, Giuseppe ;
Carteni, Giacomo ;
Caserta, Claudia ;
Sternberg, Cora N. .
CLINICAL CANCER RESEARCH, 2019, 25 (13) :3839-3846
[16]   The prognostic value of weight and body composition changes in patients with non-small-cell lung cancer treated with nivolumab [J].
Degens, Juliette H. R. J. ;
Dingemans, Anne-Marie C. ;
Willemsen, Anna C. H. ;
Gietema, Hester A. ;
Hurkmans, Daan P. ;
Aerts, Joachim G. ;
Hendriks, Lizza E. L. ;
Schols, Annemie M. W. J. .
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2021, 12 (03) :657-664
[17]   Relevance of body mass index as a predictor of systemic therapy outcomes in metastatic melanoma: analysis of the MelBase French cohort data [J].
Di Filippo, Y. ;
Dalle, S. ;
Mortier, L. ;
Dereure, O. ;
Dalac, S. ;
Dutriaux, C. ;
Leccia, M-T ;
Legoupil, D. ;
Saiag, P. ;
Brunet-Possenti, F. ;
Arnnault, J-P ;
Maubec, E. ;
Granel-Brocard, F. ;
De Quatrebarbes, J. ;
Aubin, F. ;
Lesimple, T. ;
Beylot-Barry, M. ;
Stoebner, P-E ;
Dupuy, A. ;
Stephan, A. ;
Grob, J-J ;
Lefevre, W. ;
Oriano, B. ;
Allayous, C. ;
Lebbe, C. ;
Montaudie, H. .
ANNALS OF ONCOLOGY, 2021, 32 (04) :542-551
[18]   The complex relationship between body mass index and response to immune checkpoint inhibition in metastatic melanoma patients [J].
Donnelly, Douglas ;
Bajaj, Shirin ;
Yu, Jaehong ;
Hsu, Miles ;
Balar, Arjun ;
Pavlick, Anna ;
Weber, Jeffrey ;
Osman, Iman ;
Zhong, Judy .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01)
[19]   Body mass index, adiposity and tumour infiltrating lymphocytes as prognostic biomarkers in patients treated with immunotherapy: A multi-parametric analysis [J].
Esposito, Angela ;
Marra, Antonio ;
Bagnardi, Vincenzo ;
Frassoni, Samuele ;
Morganti, Stefania ;
Viale, Giulia ;
Zagami, Paola ;
Varano, Gianluca M. ;
Buccimazza, Giorgio ;
Orsi, Franco ;
Venetis, Konstantinos ;
Mazzarella, Luca ;
Viale, Giuseppe ;
Fusco, Nicola ;
Criscitiello, Carmen ;
Curigliano, Giuseppe .
EUROPEAN JOURNAL OF CANCER, 2021, 145 :197-209
[20]   Deep Learning-Based Body Composition Analysis Predicts Outcome in Melanoma Patients Treated with Immune Checkpoint Inhibitors [J].
Faron, Anton ;
Opheys, Nikola S. ;
Nowak, Sebastian ;
Sprinkart, Alois M. ;
Isaak, Alexander ;
Theis, Maike ;
Mesropyan, Narine ;
Endler, Christoph ;
Sirokay, Judith ;
Pieper, Claus C. ;
Kuetting, Daniel ;
Attenberger, Ulrike ;
Landsberg, Jennifer ;
Luetkens, Julian A. A. .
DIAGNOSTICS, 2021, 11 (12)